Deep learning enables rapid identification of potent DDR1 kinase inhibitors; Potential 2019-nCoV 3C-like protease inhibitors designed using generative deep learning approaches; Are we opening the door to a new era of medicinal chemistry or being collapsed to a chemical singularity? Perspective; Potential non-covalent SARS-CoV-2 3C-like protease inhibitors designed using generative deep learning approaches and reviewed by human medicinal chemist in virtual reality; Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. ChemRxiv; Identification of novel antibacterials using machine learning techniques; Synthesis and biological evaluation of novel dispiro compounds based on 5-arylidenehydantoins and isatins as inhibitors of p53–mdm2 protein–protein interaction; Chemistry42: an AI-Driven platform for molecular design and optimization; Potential 2019-nCoV 3C-like protease inhibitors designed using generative deep learning approaches DNA double-strand break repair in mammalian cells; Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission; Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors; The Hitchhiker’s Guide to Deep Learning Driven Generative Chemistry; Chemistry42: An AI-based platform for de novo molecular design; Retrosynthesis-related synthetic accessibility; The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2; Large-scale High-throughput Screening Revealed 5'-(carbonylamino)-2, 3'-bithiophene-4'-carboxylate as Novel Template for Antibacterial Agents.; SARS-CoV-2 inhibitors for treating coronavirus infections; Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections; Retrosynthesis systems and methods; APPLICATION OF ARTIFICIAL INTELLIGENCE TO PREDICT THE ECOTOXICOLOGICAL CHARACTERISTICS OF AVERMECTINS
